A deep dive into the implications of the Replimune CRL that surprised insiders and investors, the role of new leadership at ...

With the executive seat open for the first time in 16 years, two prominent Democrats have emerged as frontrunners: County ...

The appointment of a seasoned pharmaceutical executive, George Tidmarsh, to run the FDA’s drug center underscores the ...